ID   NRAM2_HUMAN             Reviewed;         568 AA.
AC   P49281; B3KT08; B4DK84; F5H741; O43288; O60932; O94801; Q498Z5;
AC   Q8IUD7; Q96J35;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   10-MAY-2017, entry version 164.
DE   RecName: Full=Natural resistance-associated macrophage protein 2;
DE            Short=NRAMP 2;
DE   AltName: Full=Divalent cation transporter 1;
DE   AltName: Full=Divalent metal transporter 1;
DE            Short=DMT-1;
DE   AltName: Full=Solute carrier family 11 member 2;
GN   Name=SLC11A2; Synonyms=DCT1, DMT1, NRAMP2; ORFNames=OK/SW-cl.20;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9464519; DOI=10.1016/S0161-5890(97)00110-7;
RA   Kishi F., Tabuchi M.;
RT   "Complete nucleotide sequence of human NRAMP2 cDNA.";
RL   Mol. Immunol. 34:839-842(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=9790986; DOI=10.1006/bbrc.1998.9415;
RA   Kishi F., Tabuchi M.;
RT   "Human natural resistance-associated macrophage protein 2: gene
RT   cloning and protein identification.";
RL   Biochem. Biophys. Res. Commun. 251:775-783(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), TISSUE
RP   SPECIFICITY, AND VARIANT ILE-435.
RX   PubMed=9642100; DOI=10.1006/bcmd.1998.0186;
RA   Lee P.L., Gelbart T., West C., Halloran C., Beutler E.;
RT   "The human Nramp2 gene: characterization of the gene structure,
RT   alternative splicing, promoter region and polymorphisms.";
RL   Blood Cells Mol. Dis. 24:199-215(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1-583 (ISOFORM 3), ALTERNATIVE SPLICING (ISOFORMS 2 AND 4), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12209011; DOI=10.1073/pnas.192423399;
RA   Hubert N., Hentze M.W.;
RT   "Previously uncharacterized isoforms of divalent metal transporter
RT   (DMT)-1: implications for regulation and cellular function.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:12345-12350(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1).
RA   Worthington M.T., Battle E., Luo R.Q.;
RT   "Cloning and functional expression of the full length human NRAMP2
RT   iron transporter.";
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5).
RC   TISSUE=Brain, Thalamus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-
RT   reactive CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Hypothalamus, and Neuroblastoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 58-568 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7613023; DOI=10.1007/BF00352405;
RA   Vidal S., Belouchi A.-M., Cellier M., Beatty B., Gros P.;
RT   "Cloning and characterization of a second human NRAMP gene on
RT   chromosome 12q13.";
RL   Mamm. Genome 6:224-230(1995).
RN   [12]
RP   SUBCELLULAR LOCATION, ALTERNATIVE SPLICING, AND MUTAGENESIS OF
RP   TYR-555.
RX   PubMed=12475959; DOI=10.1091/mbc.E02-03-0165;
RA   Tabuchi M., Tanaka N., Nishida-Kitayama J., Ohno H., Kishi F.;
RT   "Alternative splicing regulates the subcellular localization of
RT   divalent metal transporter 1 isoforms.";
RL   Mol. Biol. Cell 13:4371-4387(2002).
RN   [13]
RP   FUNCTION.
RX   PubMed=17109629; DOI=10.1042/BJ20061290;
RA   Mackenzie B., Takanaga H., Hubert N., Rolfs A., Hediger M.A.;
RT   "Functional properties of multiple isoforms of human divalent metal-
RT   ion transporter 1 (DMT1).";
RL   Biochem. J. 403:59-69(2007).
RN   [14]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND NIFEDIPINE TREATMENT.
RX   PubMed=17293870; DOI=10.1038/nm1542;
RA   Ludwiczek S., Theurl I., Muckenthaler M.U., Jakab M., Mair S.M.,
RA   Theurl M., Kiss J., Paulmichl M., Hentze M.W., Ritter M., Weiss G.;
RT   "Ca2+ channel blockers reverse iron overload by a new mechanism via
RT   divalent metal transporter-1.";
RL   Nat. Med. 13:448-454(2007).
RN   [15]
RP   INTERACTION WITH NDFIP1; NDFIP2 AND WWP2, AND SUBCELLULAR LOCATION.
RX   PubMed=18776082; DOI=10.1182/blood-2008-04-150953;
RA   Foot N.J., Dalton H.E., Shearwin-Whyatt L.M., Dorstyn L., Tan S.S.,
RA   Yang B., Kumar S.;
RT   "Regulation of the divalent metal ion transporter DMT1 and iron
RT   homeostasis by a ubiquitin-dependent mechanism involving Ndfips and
RT   WWP2.";
RL   Blood 112:4268-4275(2008).
RN   [16]
RP   INTERACTION WITH NDFIP1 AND NEDD4L.
RX   PubMed=19706893; DOI=10.1073/pnas.0904880106;
RA   Howitt J., Putz U., Lackovic J., Doan A., Dorstyn L., Cheng H.,
RA   Yang B., Chan-Ling T., Silke J., Kumar S., Tan S.S.;
RT   "Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents
RT   metal toxicity in human neurons.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:15489-15494(2009).
RN   [17]
RP   ALTERNATIVE SPLICING, SUBCELLULAR LOCATION, FUNCTION, AND
RP   GLYCOSYLATION.
RX   PubMed=25491917; DOI=10.1002/cbin.10403;
RA   Yanatori I., Yasui Y., Noguchi Y., Kishi F.;
RT   "Inhibition of iron uptake by ferristatin II is exerted through
RT   internalization of DMT1 at the plasma membrane.";
RL   Cell Biol. Int. 39:427-434(2015).
RN   [18]
RP   SUBCELLULAR LOCATION, FUNCTION, AND INTERACTION WITH COX2 AND TOM6.
RX   PubMed=24448823; DOI=10.1096/fj.13-240564;
RA   Wolff N.A., Ghio A.J., Garrick L.M., Garrick M.D., Zhao L.,
RA   Fenton R.A., Thevenod F.;
RT   "Evidence for mitochondrial localization of divalent metal transporter
RT   1 (DMT1).";
RL   FASEB J. 28:2134-2145(2014).
RN   [19]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-86; ASN-89 AND
RP   MET-265.
RX   PubMed=25326704; DOI=10.1038/nsmb.2904;
RA   Ehrnstorfer I.A., Geertsma E.R., Pardon E., Steyaert J., Dutzler R.;
RT   "Crystal structure of a SLC11 (NRAMP) transporter reveals the basis
RT   for transition-metal ion transport.";
RL   Nat. Struct. Mol. Biol. 21:990-996(2014).
RN   [20]
RP   VARIANT AHMIO1 ASP-399.
RX   PubMed=15459009; DOI=10.1182/blood-2004-07-2966;
RA   Mims M.P., Guan Y., Pospisilova D., Priwitzerova M., Indrak K.,
RA   Ponka P., Divoky V., Prchal J.T.;
RT   "Identification of a human mutation of DMT1 in a patient with
RT   microcytic anemia and iron overload.";
RL   Blood 105:1337-1342(2005).
RN   [21]
RP   VARIANT AHMIO1 CYS-416.
RX   PubMed=16160008; DOI=10.1182/blood-2005-06-2477;
RA   Iolascon A., d'Apolito M., Servedio V., Cimmino F., Piga A.,
RA   Camaschella C.;
RT   "Microcytic anemia and hepatic iron overload in a child with compound
RT   heterozygous mutations in DMT1 (SCL11A2).";
RL   Blood 107:349-354(2006).
RN   [22]
RP   VARIANTS AHMIO1 VAL-114 DEL AND VAL-212.
RX   PubMed=16439678; DOI=10.1182/blood-2005-10-4269;
RA   Beaumont C., Delaunay J., Hetet G., Grandchamp B., de Montalembert M.,
RA   Tchernia G.;
RT   "Two new human DMT1 gene mutations in a patient with microcytic
RT   anemia, low ferritinemia, and liver iron overload.";
RL   Blood 107:4168-4170(2006).
RN   [23]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-48.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Important in metal transport, in particular iron. Can
CC       also transport manganese, cobalt, cadmium, nickel, vanadium and
CC       lead. Involved in apical iron uptake into duodenal enterocytes.
CC       Involved in iron transport from acidified endosomes into the
CC       cytoplasm of erythroid precursor cells. May play an important role
CC       in hepatic iron accumulation and tissue iron distribution. May
CC       serve to import iron into the mitochondria.
CC       {ECO:0000269|PubMed:17109629, ECO:0000269|PubMed:24448823,
CC       ECO:0000269|PubMed:25326704, ECO:0000269|PubMed:25491917}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 5.5-6.5 for Fe(2+) uptake.
CC         {ECO:0000269|PubMed:17293870};
CC   -!- SUBUNIT: Forms a complex with NDFIP1 and NEDD4L, in cortical
CC       neurons, in response to iron and colbalt exposure; this
CC       interaction leads to ubiquitination by NEDD4L and proteasome-
CC       dependent degradation. Interacts with NDFIP2. Interacts with COX2
CC       and TOM6 at the outer mitochondrion membrane.
CC       {ECO:0000269|PubMed:18776082, ECO:0000269|PubMed:19706893,
CC       ECO:0000269|PubMed:24448823}.
CC   -!- INTERACTION:
CC       P00403:MT-CO2; NbExp=2; IntAct=EBI-10828817, EBI-2105756;
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane
CC       {ECO:0000269|PubMed:12475959, ECO:0000269|PubMed:25491917}; Multi-
CC       pass membrane protein {ECO:0000305}. Early endosome
CC       {ECO:0000269|PubMed:12475959}.
CC   -!- SUBCELLULAR LOCATION: Endosome membrane
CC       {ECO:0000269|PubMed:12475959, ECO:0000269|PubMed:18776082,
CC       ECO:0000269|PubMed:25491917}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18776082}. Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:24448823}; Multi-pass membrane protein. Cell
CC       membrane {ECO:0000269|PubMed:12475959,
CC       ECO:0000269|PubMed:25326704, ECO:0000269|PubMed:25491917}; Multi-
CC       pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=2; Synonyms=Non-IRE, DMT1B;
CC         IsoId=P49281-1; Sequence=Displayed;
CC       Name=1; Synonyms=IRE;
CC         IsoId=P49281-2; Sequence=VSP_003595;
CC       Name=3; Synonyms=1A-IRE;
CC         IsoId=P49281-3; Sequence=VSP_038144, VSP_003595;
CC       Name=4; Synonyms=1A-Non-IRE;
CC         IsoId=P49281-4; Sequence=VSP_038144;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=P49281-5; Sequence=VSP_046058, VSP_003595;
CC         Note=No experimental confirmation available. Ref.6
CC         (BAG59096/BAH14878) sequences are in conflict in position:
CC         6:Y->S. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Isoform 1 is highly
CC       expressed in brain. Isoform 2 is highly expressed in spleen,
CC       thymus and pancreas. Isoform 3 and isoform 4 are abundantly
CC       expressed in duodenum and kidney. {ECO:0000269|PubMed:12209011,
CC       ECO:0000269|PubMed:9642100}.
CC   -!- PTM: Ubiquitinated by WWP2. {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:25491917}.
CC   -!- DISEASE: Anemia, hypochromic microcytic, with iron overload 1
CC       (AHMIO1) [MIM:206100]: A hematologic disease characterized by
CC       abnormal hemoglobin content in the erythrocytes which are reduced
CC       in size. The disorder is due to an error of iron metabolism that
CC       results in high serum iron, massive hepatic iron deposition, and
CC       absence of sideroblasts and stainable bone marrow iron store.
CC       Despite adequate transferrin-iron complex, delivery of iron to the
CC       erythroid bone marrow is apparently insufficient for the demands
CC       of hemoglobin synthesis. {ECO:0000269|PubMed:15459009,
CC       ECO:0000269|PubMed:16160008, ECO:0000269|PubMed:16439678}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: NRAMP2-mediated iron uptake is markedly stimulated
CC       by nifedipine in a concentration-dependent manner.
CC   -!- SIMILARITY: Belongs to the NRAMP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH02592.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA34374.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB004857; BAA24933.1; -; mRNA.
DR   EMBL; AB015355; BAA34374.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF064482; AAC21460.1; -; Genomic_DNA.
DR   EMBL; AF064476; AAC21460.1; JOINED; Genomic_DNA.
DR   EMBL; AF064477; AAC21460.1; JOINED; Genomic_DNA.
DR   EMBL; AF064478; AAC21460.1; JOINED; Genomic_DNA.
DR   EMBL; AF064479; AAC21460.1; JOINED; Genomic_DNA.
DR   EMBL; AF064480; AAC21460.1; JOINED; Genomic_DNA.
DR   EMBL; AF064481; AAC21460.1; JOINED; Genomic_DNA.
DR   EMBL; AF064483; AAC21461.1; -; Genomic_DNA.
DR   EMBL; AF064476; AAC21461.1; JOINED; Genomic_DNA.
DR   EMBL; AF064477; AAC21461.1; JOINED; Genomic_DNA.
DR   EMBL; AF064478; AAC21461.1; JOINED; Genomic_DNA.
DR   EMBL; AF064479; AAC21461.1; JOINED; Genomic_DNA.
DR   EMBL; AF064480; AAC21461.1; JOINED; Genomic_DNA.
DR   EMBL; AF064481; AAC21461.1; JOINED; Genomic_DNA.
DR   EMBL; AF064482; AAC21461.1; JOINED; Genomic_DNA.
DR   EMBL; AF064484; AAC21459.1; -; mRNA.
DR   EMBL; AJ493662; CAD38517.1; -; mRNA.
DR   EMBL; AF046997; AAC18078.1; -; mRNA.
DR   EMBL; AK094735; BAG52920.1; -; mRNA.
DR   EMBL; AK296445; BAG59096.1; -; mRNA.
DR   EMBL; AK316507; BAH14878.1; -; mRNA.
DR   EMBL; AB062284; BAB93467.1; -; mRNA.
DR   EMBL; AC087884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW58159.1; -; Genomic_DNA.
DR   EMBL; BC002592; AAH02592.1; ALT_INIT; mRNA.
DR   EMBL; BC100014; AAI00015.1; -; mRNA.
DR   EMBL; L37347; AAA79219.1; -; mRNA.
DR   CCDS; CCDS53791.1; -. [P49281-5]
DR   CCDS; CCDS53792.1; -. [P49281-1]
DR   CCDS; CCDS53793.1; -. [P49281-3]
DR   CCDS; CCDS8805.1; -. [P49281-2]
DR   PIR; I57022; I57022.
DR   RefSeq; NP_000608.1; NM_000617.2. [P49281-2]
DR   RefSeq; NP_001167596.1; NM_001174125.1. [P49281-3]
DR   RefSeq; NP_001167597.1; NM_001174126.1. [P49281-1]
DR   RefSeq; NP_001167598.1; NM_001174127.1. [P49281-1]
DR   RefSeq; NP_001167599.1; NM_001174128.1. [P49281-2]
DR   RefSeq; NP_001167600.1; NM_001174129.1. [P49281-2]
DR   RefSeq; NP_001167601.1; NM_001174130.1. [P49281-5]
DR   RefSeq; XP_005268968.1; XM_005268911.3. [P49281-4]
DR   RefSeq; XP_011536706.1; XM_011538404.2. [P49281-1]
DR   RefSeq; XP_011536707.1; XM_011538405.2. [P49281-1]
DR   RefSeq; XP_016874844.1; XM_017019355.1. [P49281-1]
DR   UniGene; Hs.505545; -.
DR   PDB; 5F0L; X-ray; 3.20 A; D=545-568.
DR   PDB; 5F0M; X-ray; 3.10 A; D=549-560.
DR   PDB; 5F0P; X-ray; 2.78 A; D=549-560.
DR   PDBsum; 5F0L; -.
DR   PDBsum; 5F0M; -.
DR   PDBsum; 5F0P; -.
DR   ProteinModelPortal; P49281; -.
DR   SMR; P49281; -.
DR   BioGrid; 110950; 7.
DR   DIP; DIP-48957N; -.
DR   IntAct; P49281; 4.
DR   STRING; 9606.ENSP00000378364; -.
DR   BindingDB; P49281; -.
DR   ChEMBL; CHEMBL1932895; -.
DR   GuidetoPHARMACOLOGY; 967; -.
DR   TCDB; 2.A.55.2.1; the metal ion (mn(2+)-iron) transporter (nramp) family.
DR   iPTMnet; P49281; -.
DR   PhosphoSitePlus; P49281; -.
DR   SwissPalm; P49281; -.
DR   BioMuta; SLC11A2; -.
DR   DMDM; 8247934; -.
DR   MaxQB; P49281; -.
DR   PaxDb; P49281; -.
DR   PeptideAtlas; P49281; -.
DR   PRIDE; P49281; -.
DR   DNASU; 4891; -.
DR   Ensembl; ENST00000262051; ENSP00000262051; ENSG00000110911. [P49281-1]
DR   Ensembl; ENST00000262052; ENSP00000262052; ENSG00000110911. [P49281-2]
DR   Ensembl; ENST00000394904; ENSP00000378364; ENSG00000110911. [P49281-3]
DR   Ensembl; ENST00000541174; ENSP00000444542; ENSG00000110911. [P49281-2]
DR   Ensembl; ENST00000545993; ENSP00000442810; ENSG00000110911. [P49281-5]
DR   Ensembl; ENST00000546636; ENSP00000449008; ENSG00000110911. [P49281-1]
DR   Ensembl; ENST00000547198; ENSP00000446769; ENSG00000110911. [P49281-1]
DR   Ensembl; ENST00000547688; ENSP00000449200; ENSG00000110911. [P49281-3]
DR   GeneID; 4891; -.
DR   KEGG; hsa:4891; -.
DR   UCSC; uc001rxc.5; human. [P49281-1]
DR   CTD; 4891; -.
DR   DisGeNET; 4891; -.
DR   GeneCards; SLC11A2; -.
DR   HGNC; HGNC:10908; SLC11A2.
DR   HPA; HPA032139; -.
DR   HPA; HPA032140; -.
DR   MalaCards; SLC11A2; -.
DR   MIM; 206100; phenotype.
DR   MIM; 600523; gene.
DR   neXtProt; NX_P49281; -.
DR   OpenTargets; ENSG00000110911; -.
DR   Orphanet; 83642; Microcytic anemia with liver iron overload.
DR   PharmGKB; PA259; -.
DR   eggNOG; KOG1291; Eukaryota.
DR   eggNOG; COG1914; LUCA.
DR   GeneTree; ENSGT00390000006526; -.
DR   HOVERGEN; HBG052665; -.
DR   InParanoid; P49281; -.
DR   KO; K21398; -.
DR   OMA; ERYSATK; -.
DR   OrthoDB; EOG091G05M9; -.
DR   PhylomeDB; P49281; -.
DR   TreeFam; TF315185; -.
DR   Reactome; R-HSA-425410; Metal ion SLC transporters.
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   ChiTaRS; SLC11A2; human.
DR   GeneWiki; DMT1; -.
DR   GenomeRNAi; 4891; -.
DR   PRO; PR:P49281; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000110911; -.
DR   CleanEx; HS_SLC11A2; -.
DR   ExpressionAtlas; P49281; baseline and differential.
DR   Genevisible; P49281; HS.
DR   GO; GO:0045177; C:apical part of cell; IDA:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045178; C:basal part of cell; IDA:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; ISS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0031902; C:late endosome membrane; IDA:BHF-UCL.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0070826; C:paraferritin complex; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0005773; C:vacuole; IMP:BHF-UCL.
DR   GO; GO:0046870; F:cadmium ion binding; IDA:UniProtKB.
DR   GO; GO:0015086; F:cadmium ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0015087; F:cobalt ion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005375; F:copper ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0015093; F:ferrous iron transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0015639; F:ferrous iron uptake transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0022890; F:inorganic cation transmembrane transporter activity; IGI:UniProtKB.
DR   GO; GO:0005381; F:iron ion transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015094; F:lead ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0005384; F:manganese ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0015099; F:nickel cation transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015295; F:solute:proton symporter activity; IDA:UniProtKB.
DR   GO; GO:0046915; F:transition metal ion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015100; F:vanadium ion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005385; F:zinc ion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0070574; P:cadmium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IDA:UniProtKB.
DR   GO; GO:0006824; P:cobalt ion transport; IDA:UniProtKB.
DR   GO; GO:0006825; P:copper ion transport; IDA:BHF-UCL.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0003032; P:detection of oxygen; IEP:UniProtKB.
DR   GO; GO:0048821; P:erythrocyte development; IEA:Ensembl.
DR   GO; GO:0070627; P:ferrous iron import; IDA:UniProtKB.
DR   GO; GO:0015684; P:ferrous iron transport; IDA:BHF-UCL.
DR   GO; GO:0006783; P:heme biosynthetic process; IEA:Ensembl.
DR   GO; GO:0015692; P:lead ion transport; IDA:BHF-UCL.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0006828; P:manganese ion transport; IDA:BHF-UCL.
DR   GO; GO:0060586; P:multicellular organismal iron ion homeostasis; IMP:BHF-UCL.
DR   GO; GO:0015675; P:nickel cation transport; IDA:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; IEP:UniProtKB.
DR   GO; GO:0010039; P:response to iron ion; IEP:UniProtKB.
DR   GO; GO:0015676; P:vanadium ion transport; IDA:UniProtKB.
DR   HAMAP; MF_00221; NRAMP; 1.
DR   InterPro; IPR001046; NRAMP_fam.
DR   PANTHER; PTHR11706; PTHR11706; 1.
DR   Pfam; PF01566; Nramp; 1.
DR   PRINTS; PR00447; NATRESASSCMP.
DR   TIGRFAMs; TIGR01197; nramp; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Disease mutation; Endosome; Glycoprotein; Ion transport; Iron;
KW   Iron transport; Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation.
FT   CHAIN         1    568       Natural resistance-associated macrophage
FT                                protein 2.
FT                                /FTId=PRO_0000212594.
FT   TOPO_DOM      1     69       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     70     90       Helical. {ECO:0000255}.
FT   TOPO_DOM     91     96       Extracellular. {ECO:0000255}.
FT   TRANSMEM     97    117       Helical. {ECO:0000255}.
FT   TOPO_DOM    118    154       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    155    175       Helical. {ECO:0000255}.
FT   TOPO_DOM    176    179       Extracellular. {ECO:0000255}.
FT   TRANSMEM    180    200       Helical. {ECO:0000255}.
FT   TOPO_DOM    201    208       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    209    229       Helical. {ECO:0000255}.
FT   TOPO_DOM    230    255       Extracellular. {ECO:0000255}.
FT   TRANSMEM    256    276       Helical. {ECO:0000255}.
FT   TOPO_DOM    277    301       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    302    322       Helical. {ECO:0000255}.
FT   TOPO_DOM    323    360       Extracellular. {ECO:0000255}.
FT   TRANSMEM    361    381       Helical. {ECO:0000255}.
FT   TOPO_DOM    382    408       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    409    429       Helical. {ECO:0000255}.
FT   TOPO_DOM    430    440       Extracellular. {ECO:0000255}.
FT   TRANSMEM    441    461       Helical. {ECO:0000255}.
FT   TOPO_DOM    462    482       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    483    503       Helical. {ECO:0000255}.
FT   TOPO_DOM    504    506       Extracellular. {ECO:0000255}.
FT   TRANSMEM    507    527       Helical. {ECO:0000255}.
FT   TOPO_DOM    528    568       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     564    564       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P49282}.
FT   MOD_RES     567    567       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P49282}.
FT   CARBOHYD    336    336       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    349    349       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     12       MVLGPEQKMSDD -> MSTVDYLN (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046058.
FT   VAR_SEQ       1      1       M -> MRKKQLKTEAAPHCELKSYSKNSATQVSTM (in
FT                                isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:12209011,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038144.
FT   VAR_SEQ     544    568       CHLGLTAQPELYLLNTMDADSLVSR -> VSISKGLLTEEA
FT                                TRGYVK (in isoform 1, isoform 3 and
FT                                isoform 5). {ECO:0000303|PubMed:12209011,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7613023,
FT                                ECO:0000303|PubMed:9464519,
FT                                ECO:0000303|PubMed:9642100}.
FT                                /FTId=VSP_003595.
FT   VARIANT      48     48       A -> T (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs760028045).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036434.
FT   VARIANT     114    114       Missing (in AHMIO1).
FT                                {ECO:0000269|PubMed:16439678}.
FT                                /FTId=VAR_033011.
FT   VARIANT     212    212       G -> V (in AHMIO1; dbSNP:rs121918367).
FT                                {ECO:0000269|PubMed:16439678}.
FT                                /FTId=VAR_033012.
FT   VARIANT     399    399       E -> D (in AHMIO1; increased skipping of
FT                                exon 12; dbSNP:rs121918365).
FT                                {ECO:0000269|PubMed:15459009}.
FT                                /FTId=VAR_033013.
FT   VARIANT     416    416       R -> C (in AHMIO1; dbSNP:rs121918366).
FT                                {ECO:0000269|PubMed:16160008}.
FT                                /FTId=VAR_033014.
FT   VARIANT     435    435       L -> I (in dbSNP:rs144863268).
FT                                {ECO:0000269|PubMed:9642100}.
FT                                /FTId=VAR_008882.
FT   MUTAGEN      86     86       D->A: Abolishes ion transport across the
FT                                cell membrane.
FT                                {ECO:0000269|PubMed:25326704}.
FT   MUTAGEN      89     89       N->A: Decreases affinity for divalent
FT                                metal cations. Impairs ion transport
FT                                across the cell membrane.
FT                                {ECO:0000269|PubMed:25326704}.
FT   MUTAGEN     265    265       M->A: Abolishes ion transport across the
FT                                cell membrane.
FT                                {ECO:0000269|PubMed:25326704}.
FT   MUTAGEN     555    555       Y->A: Abolishes localization at early
FT                                endosomes and leads to localization at
FT                                late endosomes and lysosomes.
FT                                {ECO:0000269|PubMed:12475959}.
FT   MUTAGEN     557    557       L->A: Abolishes localization at early
FT                                endosomes and leads to localization at
FT                                late endosomes and lysosomes.
FT                                {ECO:0000269|PubMed:12475959}.
FT   CONFLICT     58     59       PE -> GM (in Ref. 11; AAA79219).
FT                                {ECO:0000305}.
FT   CONFLICT     81     81       S -> T (in Ref. 11; AAA79219).
FT                                {ECO:0000305}.
FT   CONFLICT    119    119       Q -> K (in Ref. 10; AAI00015).
FT                                {ECO:0000305}.
FT   CONFLICT    124    124       R -> K (in Ref. 11; AAA79219).
FT                                {ECO:0000305}.
FT   CONFLICT    462    463       SL -> YV (in Ref. 11; AAA79219).
FT                                {ECO:0000305}.
FT   CONFLICT    476    476       W -> C (in Ref. 11; AAA79219).
FT                                {ECO:0000305}.
FT   STRAND      554    556       {ECO:0000244|PDB:5F0P}.
SQ   SEQUENCE   568 AA;  62266 MW;  4E45D6A448A23263 CRC64;
     MVLGPEQKMS DDSVSGDHGE SASLGNINPA YSNPSLSQSP GDSEEYFATY FNEKISIPEE
     EYSCFSFRKL WAFTGPGFLM SIAYLDPGNI ESDLQSGAVA GFKLLWILLL ATLVGLLLQR
     LAARLGVVTG LHLAEVCHRQ YPKVPRVILW LMVELAIIGS DMQEVIGSAI AINLLSVGRI
     PLWGGVLITI ADTFVFLFLD KYGLRKLEAF FGFLITIMAL TFGYEYVTVK PSQSQVLKGM
     FVPSCSGCRT PQIEQAVGIV GAVIMPHNMY LHSALVKSRQ VNRNNKQEVR EANKYFFIES
     CIALFVSFII NVFVVSVFAE AFFGKTNEQV VEVCTNTSSP HAGLFPKDNS TLAVDIYKGG
     VVLGCYFGPA ALYIWAVGIL AAGQSSTMTG TYSGQFVMEG FLNLKWSRFA RVVLTRSIAI
     IPTLLVAVFQ DVEHLTGMND FLNVLQSLQL PFALIPILTF TSLRPVMSDF ANGLGWRIAG
     GILVLIICSI NMYFVVVYVR DLGHVALYVV AAVVSVAYLG FVFYLGWQCL IALGMSFLDC
     GHTCHLGLTA QPELYLLNTM DADSLVSR
//
